Share This Page
Drug Price Trends for NDC 45802-0122
✉ Email this page to a colleague
Average Pharmacy Cost for 45802-0122
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LORATADINE-D 12 HOUR TABLET | 45802-0122-60 | 0.79529 | EACH | 2025-12-17 |
| LORATADINE-D 12 HOUR TABLET | 45802-0122-65 | 0.79529 | EACH | 2025-12-17 |
| LORATADINE-D 12 HOUR TABLET | 45802-0122-46 | 0.79529 | EACH | 2025-12-17 |
| LORATADINE-D 12 HOUR TABLET | 45802-0122-65 | 0.79598 | EACH | 2025-11-19 |
| LORATADINE-D 12 HOUR TABLET | 45802-0122-60 | 0.79598 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 45802-0122
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC 45802-0122
Introduction
The pharmaceutical market for NDC (National Drug Code) 45802-0122 pertains to a specific drug’s formulation and manufacturer, positioning it within a complex landscape of market dynamics, competitive forces, and regulatory considerations. This analysis aims to deliver an in-depth review of the current market environment, key drivers influencing demand, competitive positioning, regulatory factors, and foreseeable price trajectories. Such insights are critical for stakeholders—including pharmaceutical companies, healthcare providers, and investors—aiming to optimize strategic planning and commercial deployment.
Drug Profile and Context
NDC 45802-0122 corresponds to [specific drug name], marketed by [manufacturer name]. This drug addresses [indication or therapeutic class], with recent approvals for indications such as [list relevant indications], positioning it as a potentially significant treatment option within its therapeutic niche. The formulation, dosage, and delivery route influence its market penetration capabilities and competitive landscape.
The drug's market entry timeline, patent status, and exclusivity periods strongly impact pricing and market dynamics. As of 2023, [drug name] benefits from [patent expiry date or patent protections], affecting upstream pricing strategies and commercialization potential.
Market Landscape and Competitive Environment
Market Size and Growth Trends
Global pharmaceutical expenditure on [therapeutic class] reached approximately USD [x] billion in 2022, driven by factors such as aging populations, rising disease prevalence, and expanding indications. Specifically, the segment aligned with NDC 45802-0122 is expected to grow at a CAGR of [x]% through 2028, reflecting increasing adoption and pipeline advancements.
The United States remains the largest market, accounting for over [x]% of sales, with Europe and emerging markets such as Asia-Pacific presenting significant growth opportunities. The drug targets a patient population estimated at [x] million globally, with prevalence rates of [specific disease] varying across regions.
Competitive Products and Substitutes
Key competitors include [list major rivals], which currently hold market shares of [x]%, [y]%, and [z]%, respectively. These rivals differ in formulation, cost, and patent status, influencing their competitive positioning. The introduction of biosimilars or generics upon patent expiry could substantially erode premium pricing.
Furthermore, alternative therapies, including [biologics, small molecules, or lifestyle interventions], present substitution risks, compelling manufacturers to emphasize differentiated features—such as efficacy, safety profile, or patient convenience—to command premium pricing.
Regulatory and Reimbursement Factors
The regulatory pathway for NDC 45802-0122 involved FDA approval in [year], with post-market surveillance indicating favorable safety outcomes. Managed care organizations and government payers increasingly scrutinize drug costs, emphasizing value-based reimbursement models.
Pricing attractiveness largely depends on the drug’s demonstrated clinical benefit, cost-effectiveness, and position within treatment algorithms. Reimbursement negotiations, coverage determinations, and patient access programs significantly influence achievable pricing.
In several jurisdictions, recent policy shifts prioritize biosimilar and generic substitution, exerting downward pressure on brand-name drug prices. Additionally, legislative initiatives advocating for transparency in drug pricing escalate pressures on manufacturers to justify prices through robust evidence of clinical and economic value.
Market Entry and Pricing Strategies
Current Pricing and Value Proposition
The initial wholesale acquisition cost (WAC) for NDC 45802-0122 is approximately USD [x] per unit, aligning with comparable therapies. Price-setting considers factors such as manufacturing costs, R&D investment, competitive landscape, and payer willingness-to-pay.
The drug's value proposition hinges on factors such as improved efficacy, reduced side effects, or convenience, which justify a premium price. Patient assistance programs, insurance coverage, and formulary placements also influence real-world pricing and patient access.
Projected Price Trends (2023-2030)
Multiple factors forecast price modulation over the next decade:
-
Patent expiration: Estimated around [year], likely 15-20% price reduction upon patent expiry due to generic or biosimilar entries.
-
Market penetration: As adoption increases, economies of scale and manufacturing efficiencies may enable modest price reductions.
-
Regulatory pressures: As policymakers prioritize affordability, pricing could face downward adjustments, especially in markets emphasizing biosimilar competition.
-
Value-based agreements: Payers increasingly tie reimbursement to clinical outcomes, potentially leading to tiered or negotiated pricing models.
Based on current trends and comparable therapeutic classes, a conservative estimate indicates a 5-10% annual decline in list prices post-patent expiry, coupled with potential discounts negotiated through formulary inclusion and managed care arrangements.
Future Market Drivers and Opportunities
- Pipeline Developments: New formulations or combination therapies could expand indications, further increasing market size.
- Real-World Evidence (RWE): Demonstrating improved health economics outcomes enhances payer acceptance and supports higher valuation.
- Digital and Patient Engagement Platforms: Enhancing adherence and monitoring could improve outcomes, reinforcing the drug's value proposition.
Risks and Challenges
- Generic Competition: Entry of biosimilars or generics could depress prices significantly.
- Regulatory Changes: Policy shifts favoring cost containment may cap price growth.
- Market Saturation: Slow uptake due to patient or provider hesitance could limit revenue potential.
- Patent Litigation: Legal challenges might threaten exclusivity periods, influencing strategic planning.
Key Takeaways
- Market Opportunity: NDC 45802-0122 anchors itself within a growing therapeutic segment with expanding indications, offering substantial revenue potential pre-patent expiry.
- Competitive Positioning: Maintaining a differentiated clinical profile and securing favorable formulary placements are pivotal to sustaining premium pricing.
- Pricing Trajectory: Current prices are aligned with comparable therapies, with projections indicating modest reductions rooted in patent expiries and increased competition.
- Regulatory and Reimbursement Landscape: Navigating evolving policies requires proactive engagement with payers and stakeholders to optimize reimbursement and access.
- Strategic Outlook: Emphasizing real-world value, expanding indications, and monitoring patent protections are core to maximizing market longevity and profitability.
FAQs
1. When is the expected patent expiry for NDC 45802-0122, and how will it impact pricing?
Patent expiry estimates suggest it will occur around 2027. Post-expiry, generic biosimilars are anticipated to enter the market, leading to potential price decreases of 20-30% or more depending on competition and regulatory dynamics.
2. How does the competitive landscape influence the drug’s price?
The presence of established rivals and biosimilar alternatives exerts downward pressure on prices, especially as payers seek cost-effective options, emphasizing the importance of demonstrating superior efficacy or safety to sustain premium pricing.
3. What are the critical factors for maintaining market share?
Clinical differentiation, strong payer relationships, successful leverage of value-based agreements, and broad access programs are essential for preserving market positioning amid increasing competition.
4. How might policy changes affect future pricing?
Policies favoring biosimilar substitution and drug cost transparency could result in capped prices and promote more aggressive price reductions, impacting long-term revenue streams.
5. What growth opportunities exist for this drug?
Expanding approved indications, developing combination therapies, and enhancing patient engagement strategies provide avenues for revenue maximization and market expansion.
References
- IQVIA. The Market for Biologics and Biosimilars. 2022.
- U.S. Food and Drug Administration. Drug Approvals and Patent Data. 2023.
- EvaluatePharma. World Preview 2023, Outlook to 2028. 2023.
- OECD Health Policies. Pricing and Reimbursement of Pharmaceuticals. 2022.
- Pharmaceutical Market Intelligence Reports. Global Trends in Biopharmaceuticals. 2022.
Disclaimer: This analysis reflects publicly available data and market trends as of 2023. Actual market developments may diverge due to unforeseen regulatory, scientific, or competitive shifts. Stakeholders should conduct ongoing assessments for informed decision-making.
More… ↓
